Lv41
714 积分 2023-07-28 加入
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial
5小时前
待确认
Comparative Analysis of Proton and Carbon-Ion Therapy for Head and Neck Cancer: LET-Dependent α/β Ratios in EQD2 and NTCP
6小时前
求助中
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
4个月前
已完结
Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis
5个月前
已完结
Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma
5个月前
已完结
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma
5个月前
已完结
Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials
5个月前
已完结
Efficacy of Anti-PD1 Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis
5个月前
已完结
PD-1 blockade with camrelizumab after chemoradiotherapy in nasopharyngeal carcinoma
5个月前
已关闭
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma
5个月前
已完结
皖公网安备34019202002308
